Patent classifications
C07C251/12
Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates
4-Amino-5-fluoro-3-chloro-6-(substituted)picolinates are prepared from trifluoroacetic acid, p-methoxyaniline, a 3,3-dialkoxyprop-1-yne and a substituted methylene amine by a series of steps.
Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates
4-Amino-5-fluoro-3-chloro-6-(substituted)picolinates are prepared from trifluoroacetic acid, p-methoxyaniline, a 3,3-dialkoxyprop-1-yne and a substituted methylene amine by a series of steps.
CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG
Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-CHLORO-6-(SUBSTITUTED)PICOLINATES
4-Amino-5-fluoro-3-chloro-6-(substituted)picolinates are prepared from trifluoroacetic acid, p-methoxyaniline, a 3,3-dialkoxyprop-1-yne and a substituted methylene amine by a series of steps.
PROCESS FOR THE PREPARATION OF 4-AMINO-5-FLUORO-3-CHLORO-6-(SUBSTITUTED)PICOLINATES
4-Amino-5-fluoro-3-chloro-6-(substituted)picolinates are prepared from trifluoroacetic acid, p-methoxyaniline, a 3,3-dialkoxyprop-1-yne and a substituted methylene amine by a series of steps.
SYNTHESIS OF AN ANTIVIRAL COMPOUND
- Amy Cagulada ,
- Johann Chan ,
- Lina Chan ,
- Denise A. Colby ,
- Kapil Kumar Karki ,
- Darryl Kato ,
- Katie Ann Keaton ,
- Sudha Kondapally ,
- Christopher Levins ,
- Adam Littke ,
- Ruben Martinez ,
- Dominika Pcion ,
- Troy Reynolds ,
- Bruce Ross ,
- Michael Sangi ,
- Adam J. Schrier ,
- Pamela Seng ,
- Dustin Siegel ,
- Nathan Shapiro ,
- Donald Tang ,
- James G. Taylor ,
- Jonathan Tripp ,
- Andrew W. Waltman ,
- Lawrence Yu
The present disclosure provides processes for the preparation of a compound of formula I:
##STR00001##
which is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.
SYNTHESIS OF AN ANTIVIRAL COMPOUND
- Amy Cagulada ,
- Johann Chan ,
- Lina Chan ,
- Denise A. Colby ,
- Kapil Kumar Karki ,
- Darryl Kato ,
- Katie Ann Keaton ,
- Sudha Kondapally ,
- Christopher Levins ,
- Adam Littke ,
- Ruben Martinez ,
- Dominika Pcion ,
- Troy Reynolds ,
- Bruce Ross ,
- Michael Sangi ,
- Adam J. Schrier ,
- Pamela Seng ,
- Dustin Siegel ,
- Nathan Shapiro ,
- Donald Tang ,
- James G. Taylor ,
- Jonathan Tripp ,
- Andrew W. Waltman ,
- Lawrence Yu
The present disclosure provides processes for the preparation of a compound of formula I:
##STR00001##
which is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.
Precursors for atomic layer deposition
Atomic layer deposition (ALD) and chemical vapor deposition (CVD) precursors that are useful for forming metal-containing films are provided. These compounds include triazapentadienyl, -imino enolate compounds and -imino ketone compounds having formulae 1, 2, and 3, respectively. An ALD method using the precursors is also provided.
Precursors for atomic layer deposition
Atomic layer deposition (ALD) and chemical vapor deposition (CVD) precursors that are useful for forming metal-containing films are provided. These compounds include triazapentadienyl, -imino enolate compounds and -imino ketone compounds having formulae 1, 2, and 3, respectively. An ALD method using the precursors is also provided.